Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
Option Care Health Inc (OPCH) delivers essential home and alternate-site infusion services across all 50 states, serving patients with complex medical needs through clinical expertise and innovative care models. This dedicated news hub provides investors and healthcare professionals with timely updates on the company's strategic initiatives, financial performance, and industry leadership.
Access authoritative information about OPCH's operational milestones, including merger integrations, service expansions, and clinical protocol enhancements. Our curated collection features earnings announcements, partnership developments, and regulatory updates that shape the home infusion care landscape.
Key content categories include quarterly financial disclosures, leadership changes, treatment innovation announcements, and market position analyses. This resource enables stakeholders to monitor OPCH's progress in improving patient outcomes while maintaining cost-effective care delivery systems.
Bookmark this page for continuous access to verified OPCH developments. Combine regular monitoring with professional financial analysis when evaluating the company's role in evolving healthcare markets.
Option Care Health announced an affiliate of Walgreens Boots Alliance will sell 11 million shares of the Company’s common stock at $33.25 per share in a secondary offering. This represents about 6% of the current shares outstanding. The offering is expected to close on August 18, 2022, subject to customary conditions. Goldman Sachs is the underwriter for the offering. Option Care Health will not receive any proceeds from this transaction. A shelf registration statement was filed with the SEC for these shares.
Option Care Health announced an underwritten secondary offering of 11 million shares by an affiliate of Walgreens Boots Alliance, representing approximately 6.0% of its outstanding shares. The offering, managed by Goldman Sachs, will not generate proceeds for the company. A shelf registration statement has been filed with the SEC to facilitate this process. Although the offering can potentially affect stock availability, it is not expected to impact the company's financial position directly.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., has announced its participation in two investor conferences. The BofA Securities SMID Cap Ideas Conference will be held virtually on August 10, 2022, featuring a fireside chat at 9:40 am ET. Following that, the Morgan Stanley 20th Annual Global Healthcare Conference is set for September 12, 2022, in New York, with a fireside chat at 8:45 am ET. Additional information and presentations will be available online.
Option Care Health reported strong second quarter 2022 financial results, with net revenue of $980.8 million, a 14.0% increase from $860.3 million in Q2 2021. Gross profit reached $216.9 million (22.1% of revenue), up 9.0% year-over-year. Net income was $33.9 million ($0.19 per share), compared to $31.8 million ($0.18 per share) last year. Adjusted EBITDA increased 17.0% to $85.2 million. Cash flow from operations improved to $104.4 million. The company also completed the acquisition of Specialty Pharmacy Nursing Network for $60.0 million.
Option Care Health (NASDAQ: OPCH) will announce its second-quarter results on July 27, 2022, before market opening. The management team will host a conference call at 8:30 a.m. ET to discuss the results. Option Care Health is recognized as the largest independent provider of home and alternate site infusion services in the U.S., employing over 7,000 individuals, including 4,000 clinicians. The company is dedicated to enhancing patient care for both acute and chronic conditions across all 50 states.
Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., announced its participation in several upcoming investor conferences. These include the William Blair 42nd Annual Growth Stock Conference on June 7, 2022, the Jefferies Healthcare Conference on June 9, 2022, and the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022. Each event features a fireside chat presentation. More details and webcast links can be found on their investor relations website.
Option Care Health, the largest independent national provider of home infusion services, will participate in the BofA Securities 2022 Healthcare Conference on May 10, 2022, in Las Vegas. The event will feature a fireside chat at 11:20 AM PT, with an audio replay available online afterward. Option Care Health employs over 7,000 team members, including more than 4,000 clinicians, dedicated to improving patient care for acute and chronic conditions across all 50 states. For more information, visit OptionCareHealth.com.
Option Care Health reported a robust first quarter for 2022, achieving net revenue of $915.8 million, a 20.6% increase from $759.2 million in Q1 2021. The gross profit rose to $200.9 million, representing 21.9% of net revenue. The company posted a net income of $30.3 million ($0.17 per share), recovering from a net loss of $2.9 million the prior year. Additionally, Adjusted EBITDA surged by 48.9% to $77.8 million. For 2022, guidance projects revenue between $3.75 billion and $3.90 billion.
Option Care Health (Nasdaq: OPCH) announced the acquisition of Specialty Pharmacy Nursing Network Inc. (SPNN) for $60 million in cash, finalized on April 11, 2022. This acquisition enhances Option Care's nursing capabilities, expanding its team to over 2,900 nurses nationwide. SPNN, a leader in providing specialized nursing resources, will continue its operations as a separate unit within Option Care Health. CEO John Rademacher emphasized that this move aligns with their strategy to improve infusion care and ensures future growth opportunities.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced its first quarter financial results will be released on April 28, 2022. The management team will host a conference call at 8:30 a.m. E.T. to discuss these results. Investors can access the call by phone or through a live audio webcast. A replay will be available for on-demand listening afterward. Option Care Health serves patients with acute and chronic conditions nationwide, employing over 7,000 team members, including more than 4,000 clinicians.